Aliskiren and Renin Inhibition in Diastolic Heart Failure in Mexican Americans.

Trial Profile

Aliskiren and Renin Inhibition in Diastolic Heart Failure in Mexican Americans.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 16 May 2015

At a glance

  • Drugs Aliskiren (Primary) ; Lisinopril; Spironolactone
  • Indications Chronic heart failure
  • Focus Biomarker; Therapeutic Use
  • Acronyms ARID-HF
  • Most Recent Events

    • 02 Mar 2011 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 01 May 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 09 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top